BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12548600)

  • 21. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium.
    Enestvedt BK; Gralnek IM; Mattek N; Lieberman DA; Eisen G
    Gastrointest Endosc; 2008 Mar; 67(3):422-9. PubMed ID: 18206878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal Involvement in Patients with Mantle Cell Lymphoma: A Single Center Experience of Eighty-Five Patients.
    Lamm W; Dolak W; Kiesewetter B; Simonitsch-Klupp I; Puhr H; Raderer M
    Dig Dis; 2019; 37(3):194-200. PubMed ID: 30677768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies.
    Ross WA; Ghosh S; Dekovich AA; Liu S; Ayers GD; Cleary KR; Lee JH; Couriel D
    Am J Gastroenterol; 2008 Apr; 103(4):982-9. PubMed ID: 18028511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
    Romaguera JE; Fayad L; Rodriguez MA; Broglio KR; Hagemeister FB; Pro B; McLaughlin P; Younes A; Samaniego F; Goy A; Sarris AH; Dang NH; Wang M; Beasley V; Medeiros LJ; Katz RL; Gagneja H; Samuels BI; Smith TL; Cabanillas FF
    J Clin Oncol; 2005 Oct; 23(28):7013-23. PubMed ID: 16145068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quality of diagnostic procedures and frequency of endoscopically defined diseases of the upper gastrointestinal tract].
    Bartels F; Hahn HJ; Stolte M; Schmidt-Wilcke HA
    Z Gastroenterol; 2003 Apr; 41(4):311-8. PubMed ID: 12695936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mantle cell lymphoma with gastrointestinal involvement and the role of endoscopic examinations.
    Lee HH; Cho SG; Lee IS; Cho HJ; Jeon YW; O JH; Jung SE; Choi BO; Park KS; Yang SW
    PLoS One; 2020; 15(9):e0239740. PubMed ID: 32976548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What to do when you suspect gastrointestinal lymphoma: a pathologist's perspective.
    Gurbuxani S; Anastasi J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):417-21. PubMed ID: 17336592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capsule endoscopy in gastrointestinal lymphomas.
    Flieger D; Keller R; May A; Ell C; Fischbach W
    Endoscopy; 2005 Dec; 37(12):1174-80. PubMed ID: 16329013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.
    Garcia M; Romaguera JE; Inamdar KV; Rassidakis GZ; Medeiros LJ
    Cancer; 2009 Mar; 115(5):1041-8. PubMed ID: 19170236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal Mantle Cell Lymphoma-A Tale of Two Endoscopies.
    Dantoc MM; Eslick GD; Adams SS; Kalantar JS
    J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S20-4. PubMed ID: 21556723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.
    Evens AM; Winter JN; Hou N; Nelson BP; Rademaker A; Patton D; Singhal S; Frankfurt O; Tallman MS; Rosen ST; Mehta J; Gordon LI
    Br J Haematol; 2008 Feb; 140(4):385-93. PubMed ID: 18162124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-balloon enteroscopy in patients with GI bleeding of obscure origin.
    Manabe N; Tanaka S; Fukumoto A; Nakao M; Kamino D; Chayama K
    Gastrointest Endosc; 2006 Jul; 64(1):135-40. PubMed ID: 16813826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synchronous primary gastric mantle cell lymphoma and early gastric carcinoma: a case report.
    Chong Y; Shin JJ; Cho MY; Cui Y; Kim HY; Park KH
    Pathol Res Pract; 2008; 204(6):407-11. PubMed ID: 18282664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
    Inamdar KV; Romaguera JE; Drakos E; Knoblock RJ; Garcia M; Leventaki V; Medeiros LJ; Rassidakis GZ
    Cancer; 2009 Oct; 115(20):4727-36. PubMed ID: 19708031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy.
    Canga C; Vakil N
    Am J Gastroenterol; 2002 Mar; 97(3):600-3. PubMed ID: 11922553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT).
    Rosenbluth BD; Yahalom J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1185-91. PubMed ID: 16682133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.